logo
Twitter
Discord
Email
logo
Lincoln National Corporation

Lincoln National Corporation

NYSE•LNC
CEO: Ms. Ellen R. Gail Cooper C.F.A., F.S.A.
Sector: Financial Services
Industry: Insurance - Life
Listing Date: 1980-03-17
Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates in four segments: Life Insurance, Annuities, Group Protection, and Retirement Plan Services. The Life Insurance segment provides life insurance products, including term insurance, universal life insurance (UL), indexed universal life insurance, variable universal life insurance (VUL), linked-benefit UL and VUL products, and critical illness and long-term care riders. The Annuities segment offers variable, fixed, and registered index-linked annuities. The Group Protection segment offers group non-medical insurance products consisting of short and long-term disability and statutory disability; paid family medical leave administration and absence management services; term life; dental and vision; and accident, critical illness, and hospital indemnity benefits and services to the employer marketplace through various forms of employee-paid and employer-paid plans. The Retirement Plan Services segment provides employers with retirement plan products and services primarily in the defined contribution retirement plan marketplace; individual and group variable annuities, group fixed annuities, and mutual fund-based programs; and various plan services, including plan recordkeeping, compliance testing, participant education, and trust and custodial services. The company distributes its products through consultants, brokers, planners, agents, financial advisors, third-party administrators, and other intermediaries. Lincoln National Corporation was founded in 1905 and is headquartered in Radnor, Pennsylvania.
Contact Information
150 North Radnor-Chester Road, Suite A305, Radnor, PA, 19087, United States
484-583-1400
www.lincolnfinancial.com
Market Cap
$8.08B
P/E (TTM)
3.8
13.8
Dividend Yield
4.2%
52W High
$43.66
52W Low
$27.58
52W Range
93%
Rank42Top 35.8%
4.3
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 4.3 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q3 2025 Data

Revenue

$4.59B+30.95%
4-Quarter Trend

EPS

$2.15-165.35%
4-Quarter Trend

FCF

-$1.14B+4125.93%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Quarterly Net Income Rebounds Q3 net income was 445M USD, reversing prior year's 528M USD loss; 9-month net income fell to 423M USD from 1.59B USD.
Annuities Segment Performance Strong Annuities segment income from operations grew to 886M USD for nine months, driven by higher fee income and average daily balances.
Life Insurance Turns Profitable Life Insurance segment income from operations was 40M USD for nine months, a significant turnaround from 48M USD loss last year.
Equity Position Strengthened Total stockholders' equity increased to 10.45B USD as of September 30, 2025, supported by common stock issuance proceeds.

Risk Factors

Level 3 Asset Valuation Exposure Significant portion of investments, 13.44B USD, relies on Level 3 inputs, requiring complex valuation assumptions and judgments.
Litigation Contingency Exposure Contingencies include ongoing litigation matters, with one matter having a provisional settlement of 147.5M USD pre-tax accrued.
Interest Rate Volatility Risks Fluctuations in interest rates impact investment income and profitability, especially concerning general account assets supporting annuity liabilities.
Credit Quality Deterioration Possible Gross unrealized losses on fixed maturity AFS securities totaled 8.97B USD as of September 30, 2025, primarily due to rising interest rates.

Outlook

Federal Reserve Policy Shifts Federal Reserve announced rate cuts during Q3 2025, targeting 3.75% to 4.00% range, ending balance sheet reduction in December 2025.
Capital Deployment Strategy Capital from June 2025 Bain transaction (825M USD) expected to deploy toward strategic priorities like growing spread-based earnings.
Future Goodwill Impairment Test Annual quantitative goodwill impairment test scheduled for October 1, 2025, on all reporting units, requiring management assessment.
Litigation Resolution Efforts Vigorously defending multiple class action lawsuits, including appealing the Glover provisional settlement outcome, subject to final court approval.

Peer Comparison

Revenue (TTM)

MetLife, Inc.MET
$71.29B
-0.1%
Prudential Financial, Inc.PRU
$57.91B
-13.2%
Manulife Financial CorporationMFC
$49.05B
+41.4%

Gross Margin (Latest Quarter)

Manulife Financial CorporationMFC
22.2%
-162.0pp
Jackson Financial Inc.JXN
0.0%
+0.0pp
Prudential plcPUK
0.0%
+0.0pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
MFC$59.41B13.911.9%1.3%
AFL$59.10B13.915.4%0.0%
MET$51.41B13.513.8%2.8%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-8.5%
Growth Under Pressure
4Q Net Income CAGR
-35.9%
Declining Profitability
Cash Flow Stability
50%
Cash Flow Needs Attention

Research & Insights

Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Oct 30, 2025|
    Revenue: $4.59B+30.9%
    |
    EPS: $2.15-165.3%
    Meet
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 31, 2025|
    Revenue: $4.07B-11.3%
    |
    EPS: $3.88-25.1%
    Meet
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 8, 2025|
    Revenue: $4.69B+14.0%
    |
    EPS: $-4.41-163.1%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 21, 2025|
    Revenue: $17.99B+27.9%
    |
    EPS: $18.66+479.3%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Oct 31, 2024|
    Revenue: $3.51B-16.6%
    |
    EPS: $-3.29-168.1%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 1, 2024|
    Revenue: $4.58B+56.1%
    |
    EPS: $5.18+75.0%
    Beat
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 2, 2024|
    Revenue: $4.11B+7.9%
    |
    EPS: $6.99-234.4%
    Meet
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 22, 2024|
    Revenue: $11.65B-25.7%
    |
    EPS: $-4.43-162.0%
    Miss